Skip to main content
Stephanie Cham, MD, Obstetrics & Gynecology, San Francisco, CA

Stephanie Cham MD

Gynecologic Oncology


Physician

Join to View Full Profile
  • 1825 4th StFl 6San Francisco, CA 94143

  • Phone+1 415-353-9600

Dr. Cham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Stephanie Cham is an obstetrician/gynecologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center, Kaiser Permanente San Francisco Medical Center, and Kaiser Permanente San Francisco Medical Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 4 years. She specializes in gynecologic oncology. She has more than 10 publications and over 250 citings.

Education & Training

  • Mass General Brigham/Brigham and Women’s Hospital
    Mass General Brigham/Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2019
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2016 - 2019
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2015

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2019 - 2023
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Publications & Presentations

PubMed

Press Mentions

  • BRCA Testing Is Not Widely Used in Women with Ovarian Cancer
    BRCA Testing Is Not Widely Used in Women with Ovarian CancerJanuary 14th, 2022
  • BRCA Testing Underused in Women with Ovarian Cancer
    BRCA Testing Underused in Women with Ovarian CancerJanuary 14th, 2022
  • Germline BRCA Testing Underutilized in Ovarian Cancer
    Germline BRCA Testing Underutilized in Ovarian CancerOctober 1st, 2021
  • Join now to see all

Grant Support

  • Promoting gynecologic cancer patients with frailty to achieve functional recovery cohort study (PROOF Cohort Study)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: